Open AccessPharmacometrics: Opportunity for Reducing Disease Burden in the Developing World: The Case of Africa
Author(s) -
Pillai G,
Davies G,
Denti P,
Steimer JL,
McIlleron H,
Zvada S,
Chigutsa E,
Ngaimisi E,
Mirza F,
Tadmor B,
Holford NHG
Publication year - 2013
Publication title -
cpt: pharmacometrics and systems pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.53
H-Index - 37
ISSN - 2163-8306
DOI - 10.1038/psp.2013.45
Subject(s) - developing country , burden of disease , disease burden , medicine , disease , infectious disease (medical specialty) , intensive care medicine , economic growth , pathology , economics
Pharmacometricians are virtually nonexistent in Africa and the developing world. The unrelenting burden of infectious diseases, which are often treated using medicines with narrow effectiveness and safety dose ranges, and the growing prevalence and recognition of non‐communicable diseases represent significant threats for the patients, although affording an opportunity for advancing science. This article outlines the case for pharmacometricians to redirect their expertise to focus on the disease burden affecting the developing world. CPT: Pharmacometrics & Systems Pharmacology (2013) 2, e69; doi: 10.1038/psp.2013.45 ; published online 28 August 2013